Serum angiopoietin-like protein 2 concentrations are independently associated with heart failure

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Huang, Chi Lun ^a,b   Wu, Yen Wen ^b,c,d   Wu, Chih Cheng ^b   Hwang, Juey Jen ^b   Yang, Wei Shiung ^b,e  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 2; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FATTY ACID BINDING PROTEIN 4; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANGPTL2 PROTEIN, HUMAN; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE PERFUSION; HIGH RISK PATIENT; HUMAN; LEFT ATRIAL DIMENSION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STRESS HEART MUSCLE PERFUSION; TAIWANESE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; DEMOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; RISK FACTOR; TAIWAN; VERY ELDERLY;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; ANGIOPOIETINS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DEMOGRAPHY; ECHOCARDIOGRAPHY; FATTY ACID-BINDING PROTEINS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TAIWAN;

EID: 84946926065     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138678     Document Type: Article

References (36)

1. Santulli G. (2013) Epidemiology of Cardiovascular Disease in the 21 century: update numbers and update facts. J Cardiovas Dis 1:1-2.
2. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996-1002. PMID: 11295963
3. Gaddam KK, Ventura HO, Lavie CJ. (2011) Metabolic syndrome and heart failure-the risk, paradox, and treatment. Curr Hypertens Rep 13:142-8. doi: 10.1007/s11906-011-0179-x PMID: 21298579
4. Rame JE. (2012) Chronic heart failure: a reversible metabolic syndrome? Circulation 125:2809-11 doi: 10.1161/CIRCULATIONAHA.112.108316 PMID: 22586280
5. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 23:236-41.
6. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, et al. (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 28:829-35. PMID: 17403719
7. Kadomatsu T, Tabata M, Oike Y. (2011) Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS J 278:559-64. doi: 10.1111/j.1742-4658.2010.07979.x PMID: 21182596
8. Kadomatsu T, Endo M, Miyata K, Oike Y. (2014) Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab 25:245-54. doi: 10.1016/j.tem.2014.03.012 PMID: 24746520
9. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, et al. (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10:178-88. doi: 10.1016/j.cmet.2009.08.003 PMID: 19723494
10. Doi Y, Ninomiya T, Hirakawa Y, Takahashi O, Mukai N, Endo M, et al. (2013) Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 36:98-100. doi: 10.2337/dc12-0166 PMID: 22966088
11. Tian Z, Miyata K, Tazume H, Sakaguchi H, Kadomatsu T, Horio E, et al. (2013) Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol 57:1-12. doi: 10.1016/j.yjmcc.2013.01.004 PMID: 23333801
12. Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, et al. (2014) Role of endothelial cellderived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 34:790-800. doi: 10.1161/ATVBAHA.113.303116 PMID: 24526691
13. Farhat N, Thorin-Trescases N, Mamarbachi M, Villeneuve L, Yu C, Martel C, et al. (2013) Angiopoietinlike 2 promotes atherogenesis in mice. J Am Heart Assoc 2:e000201. doi: 10.1161/JAHA.113.000201 PMID: 23666461
14. Wang Z, Zheng H, Chen H, Lin X, Chen J, Wang L, et al. (2015) Elevated Serum Angiopoietin-like Protein 2 in Patients with Acute Coronary Syndrome. Arch Med Res 46:257-64. doi: 10.1016/j.arcmed. 2015.05.003 PMID: 25999029
15. Jung CH, Lee WJ, Lee MJ, Kang YM, Jang JE, Leem J, et al. (2015) Association of serum angiopoietinlike protein 2 with carotid intima-media thickness in subjects with type 2 diabetes. Cardiovasc Diabetol 14:35. doi: 10.1186/s12933-015-0198-z PMID: 25889082
16. Bonow RO, Bennett S, Casey DE Jr, Ganiats TG, Hlatky MA, Konstam MA, et al. (2005) ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 46:1144-78. PMID: 16168305
17. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al. (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539-50. PMID: 17428822
18. Wu YW, Yen RF, Chieng PU, Huang PJ. (2003) Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardio 10:369-374.
19. Tilkemeier PL, Wackers FJ, Quality Assurance Committee of the American Society of Nuclear Cardiology. (2006) Myocardial perfusion planar imaging. J Nucl Cardiol 13:e91-6. PMID: 17174799
20. Dvorak RA, Brown RK, Corbett JR. (2011) Interpretation of SPECT/CT myocardial perfusion images: common artifacts and quality control techniques. Radiographics 31:2041-57. doi: 10.1148/rg. 317115090 PMID: 22084188
21. Santulli G. (2014) Angiopoietin-like proteins: a comprehensive look. Front Endocrinol (Lausanne) 5:4.
22. Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, et al. (2010) Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 176:2309-19. doi: 10.2353/ajpath.2010.090865 PMID: 20304962
23. Ogata A, Endo M, Aoi J, Takahashi O, Kadomatsu T, Miyata K, et al. (2012) The role of angiopoietinlike protein 2 in pathogenesis of dermatomyositis. Biochem Biophys Res Commun 418:494-9. doi: 10. 1016/j.bbrc.2012.01.052 PMID: 22281496
24. Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, et al. (2011) Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 71:7502-12. doi: 10.1158/0008-5472.CAN-11-1758 PMID: 22042794
25. Tazume H, Miyata K, Tian Z, Endo M, Horiguchi H, Takahashi O, et al. (2012) Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 32:1400-9. doi: 10.1161/ATVBAHA.112.247866 PMID: 22556334
26. Shinmura K. (2010) Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease. Heart Fail Rev 15:457-66. doi: 10.1007/s10741-010-9159-5 PMID: 20204504
27. Kralisch S, Fasshauer M. (2013) Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 56:10-21. doi: 10.1007/s00125-012-2737-4 PMID: 23052058
28. Djoussé L, Bartz TM, Ix JH, Kochar J, Kizer JR, Gottdiener JS, et al. (2013) Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study. Eur J Heart Fail 15:394-9. doi: 10.1093/eurjhf/hfs196 PMID: 23223158
29. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245-50. PMID: 15326067
30. Takeishi Y, Niizeki T, Arimoto T, Nozaki N, Hirono O, Nitobe J, et al. (2007) Serum resistin is associated with high risk in patients with congestive heart failure-a novel link between metabolic signals and heart failure. Circ J 71:460-4. PMID: 17384443
31. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, et al. (2006) Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92:1420-4. PMID: 16621874
32. Djoussé L, Bartz TM, Ix JH, Kochar J, Kizer JR, Gottdiener JS, et al. (2013) Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study. Eur J Heart Fail 15:394-9. doi: 10.1093/eurjhf/hfs196 PMID: 23223158
33. Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, et al. (2012) Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J 163:119-124. doi: 10.1016/j.ahj.2011.09.029 PMID: 22172445
34. Kim M, Oh JK, Sakata S, Liang I, Park W, Hajjar RJ, et al. (2008) Role of resistin in cardiac contractility and hypertrophy. J Mol Cell Cardiol 45:270-80. doi: 10.1016/j.yjmcc.2008.05.006 PMID: 18597775
35. Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schunck WH, et al. (2009) Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105:326-34. doi: 10.1161/CIRCRESAHA.109.200501 PMID: 19608978
36. Li Q, Gong W, Yang Z, Lu B, Yang Y, Zhao W, et al. (2013) Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diabetes Res Clin Pract 100:385-90. doi: 10.1016/j. diabres.2013.03.028 PMID: 23602322